Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tarsus Pharmaceuticals, Inc. (TARS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 33,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Tarsus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Co.'s primary product candidate, TP-03, is an investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. Co. is developing product candidates to address targeted diseases with unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease, TP-04 for the potential treatment of rosacea, and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 1,000 10,506 28,906
Total Buy Value $0 $18,960 $178,661 $475,267
Total People Bought 0 1 2 2
Total Buy Transactions 0 1 2 3
Total Shares Sold 28,810 103,773 277,520 1,365,143
Total Sell Value $881,586 $2,318,498 $5,607,786 $9,074,655
Total People Sold 5 6 6 9
Total Sell Transactions 5 11 25 115
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 211
  Page 8 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ackermann Michael Director   –       •      –    2021-08-09 4 AS $25.00 $17,500 D/D (700) 1,227,969     -
   Azamian Bobak R. President and CEO   •       •      –    2021-08-09 4 AS $25.00 $20,688 I/I (827) 1,229,458     -
   Ackermann Michael Director   –       •      –    2021-08-06 4 AS $25.00 $78,225 D/D (3,129) 1,228,669     -
   Azamian Bobak R. President and CEO   •       •      –    2021-08-06 4 AS $25.00 $40,400 I/I (1,616) 1,230,285     -
   Ackermann Michael Director   –       •      –    2021-08-05 4 AS $25.00 $34,577 D/D (1,383) 1,231,798     -
   Azamian Bobak R. President and CEO   •       •      –    2021-08-05 4 AS $25.00 $34,250 I/I (1,370) 1,231,901     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-06-25 4 S $29.60 $228,038 I/I (7,704) 2,987,331     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-06-24 4 S $29.90 $299,000 I/I (10,000) 2,995,035     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-06-23 4 S $29.80 $1,131,804 I/I (37,980) 3,005,035     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-06-22 4 S $28.50 $3,135,000 I/I (110,000) 3,043,015     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-06-21 4 S $29.70 $2,721,114 I/I (91,620) 3,153,015     -
   Ackermann Michael Director   –       •      –    2021-06-15 4 A $0.00 $0 D/D 4,257 1,233,181     -
   Wong Roderick 10% Owner   –       –       •   2021-05-07 4 S $29.98 $13,491,000 I/I (450,000) 2,013,601     -
   Vivo Capital Fund Ix, L.p. 10% Owner   –       –       •   2021-04-14 4 S $30.37 $12,148 I/I (400) 3,244,635     -
   Wahl Bryan General CounselOfficer   •       –      –    2021-01-19 3 IO $0.00 $0 D/D 0 5,000     -
   Horowitz Limited Partnership Viii 10% Owner   –       –       •   2020-10-20 4 B $16.00 $250,000 I/I 15,625 66,172 1.5     -
   Horowitz Limited Partnership Viii 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 I/I 50,547 50,547     -
   Horowitz Limited Partnership Viii 10% Owner   –       –       •   2020-10-20 4 B $16.00 $2,700,000 D/D 168,750 1,920,933 2.45     -
   Horowitz Limited Partnership Viii 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 D/D 1,752,183 1,752,183     -
   Heron Patrick J 10% Owner   –       –       •   2020-10-20 4 B $16.00 $5,000,000 D/D 312,500 1,917,157 2.45     -
   Heron Patrick J 10% Owner   –       –       •   2020-10-20 4 A $0.00 $0 D/D 1,604,657 1,604,657     -
   Ackermann Michael Director   –       •       •   2020-10-20 4 A $0.00 $0 D/D 63,185 1,228,924     -
   Tester Jason E. Director   –       •       •   2020-10-20 4 B $16.00 $2,750,000 I/I 171,875 1,920,933 2.25     -
   Tester Jason E. Director   –       •       •   2020-10-20 4 A $0.00 $0 I/I 1,777,456 1,752,183     -
   Link William J Phd Director   –       •      –    2020-10-20 4 A $0.00 $0 I/I 1,112,301 1,112,301     -
  211 Records found
  1  2  3  4  5  6  7  8  9   
  Page 8 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us